Pancreatic Cancer Research

ResearcherInner Mongolia Medical UniversityActive in the last 2 years

Jian-jun Ren

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4367-5409; OpenAlex author ID A5103101201. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 4

  1. FABP4 interacts with PPARγ to promote malignant progression in pancreatic cancer. Co-author DOI 10.1016/j.isci.2026.116547↗
  2. A novel AGTPBP1-ERK/MYLK network mediates pancreatic cancer progression. Last author DOI 10.1016/j.tice.2026.103512↗
  3. Targeting AGTPBP1 inhibits pancreatic cancer progression via regulating microtubules and ERK signaling pathway. Last author DOI 10.1186/s10020-024-00892-x↗
  4. The Wnt/β-catenin signaling pathway mechanism for pancreatic cancer chemoresistance in a three-dimensional cancer microenvironment. Last author PMID 27830034↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rui Xiao · 3 shared papers, 2024–2026 · strength 0.86
  2. Jingrui Yang · 1 shared paper, 2026 · strength 0.32
  3. Zhe-yu Yang · 1 shared paper, 2026 · strength 0.32
  4. Chenxi Yang · 1 shared paper, 2026 · strength 0.32
  5. Ding-zhong Li · 1 shared paper, 2024 · strength 0.23
  6. Qian Zhang · 1 shared paper, 2024 · strength 0.23
  7. Qiang Zhang · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.